Brick, NJ, United States of America

Mark Cameron

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 67(Granted Patents)


Location History:

  • Bishops Stortford, GB (1997 - 2002)
  • Brick, NJ (US) (2009 - 2017)

Company Filing History:


Years Active: 1997-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Mark Cameron: Pioneering Innovations in Oligonucleotide Delivery**

Introduction

Mark Cameron, an accomplished inventor based in Brick, NJ, has made significant contributions to the field of biomedical engineering through his innovative developments in oligonucleotide delivery systems. With an impressive portfolio of 7 patents, Cameron continues to push the boundaries of technology in an era where precision medicine is becoming increasingly vital.

Latest Patents

Two of Mark Cameron's latest patents focus on the development of cationic lipids with various head groups for oligonucleotide delivery. The invention presents novel cationic lipids that can be combined with other lipid components, such as cholesterol and PEG-lipids. These lipid nanoparticles can encapsulate siRNA, facilitating cellular uptake and endosomal escape. This technology aims to effectively knock down target mRNA both in vitro and in vivo, showcasing the advancements in therapeutic strategies for genetic disorders and targeted treatments.

Career Highlights

Throughout his career, Mark Cameron has worked with prestigious organizations that have honed his skills and expertise. Notably, he has been associated with Merck & Company, Inc. and Sirna Therapeutics, Inc., where he contributed to groundbreaking research and development projects. His experience in these companies has provided a strong foundation for his innovative pursuits in the field of drug delivery systems.

Collaborations

Mark Cameron has collaborated with notable colleagues such as Ian Frank Cottrell and Ulf H. Dolling. These partnerships have fostered an environment of creativity and innovation, allowing them to develop and refine their ideas to bring cutting-edge solutions to the market.

Conclusion

Mark Cameron's contributions to the field of oligonucleotide delivery and his innovative spirit underline the importance of research and development in biotechnology. With existing and future patents, he continues to make strides in medical technology, ultimately aiming to enhance therapeutic outcomes for patients. His journey exemplifies the relentless pursuit of innovation and the impact it can have on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…